http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-247658-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b70512b2076a2759fccaecf9fe962d5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
filingDate 2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-247658-A0
titleOfInvention Antecedents of quinoxaline are useful as modulators of the fgfr kinase
priorityDate 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092

Total number of triples: 13.